A Look At Align Technology (ALGN) Valuation As Elliott Investment Management Takes A Major Stake

NodeGuardian · 2026-03-30T15:06:06+00:00

Elliott Investment Management has acquired a significant stake in Align Technology, presenting two contrasting valuations: one suggests a 12% overvaluation at $154.62, while the other indicates a 19% undervaluation at $214.68. Investors are advised to analyze both viewpoints.

NodeGuardian

2026-03-30 15:06:06

Abstract generation in progress

Elliott Investment Management has become a major shareholder in Align Technology (ALGN), aiming to improve stock performance. The article presents two valuation narratives for ALGN: one suggesting it’s 12% overvalued with a fair value of $154.62 based on medical credibility and innovation, and another indicating it’s 19% undervalued at $214.68 according to a Discounted Cash Flow (DCF) model. Investors are encouraged to consider both perspectives and conduct their own analysis on the company, which manufactures Invisalign clear aligners and iTero scanners.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.